Evidence map›Paper›PMID 33577585›Full record

ArticlePloS one2021

Alteration of oxidative-stress and related marker levels in mouse colonic tissues and fecal microbiota structures with chronic ethanol administration: Implications for the pathogenesis of ethanol-related colorectal cancer.

Hideo Ohira, Atsuki Tsuruya, Daiki Oikawa, Wao Nakagawa, Rie Mamoto, Masahira Hattori, Toshiyuki Waki, Seiji Takahashi, Yoshio Fujioka, Toru Nakayama

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. LipReg4 deletion blocks hypertension induced by gut S. aureofaciens Tü117.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Gut Microbiome Interactions with Oxidative Stress: Mechanisms and Consequences for Health.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hideo OhiraDivision of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan.ORCID 0000-0002-1723-7173
Atsuki TsuruyaDepartment of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan.
Daiki OikawaDepartment of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan.
Wao NakagawaDivision of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan.
Rie MamotoDivision of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan.
Masahira HattoriGraduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Toshiyuki WakiDepartment of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan.
Seiji TakahashiDepartment of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan.
Yoshio FujiokaDivision of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan.
Toru NakayamaDepartment of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan.
Tohoku University · JPKobe Gakuin University · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic ethanol consumption is a risk factor for colorectal cancer, and ethanol-induced reactive oxygen species have been suggested to play important roles in the pathogenesis of ethanol-related colorectal cancer (ER-CRC). In this study, the effects of 10-week chronic administration of ethanol on the colonic levels of oxidative stress and advance glycation end product (AGE) levels, as well as fecal microbiota structures, were examined in a mouse model. Chronic oral administration of ethanol in mice (1.0 mL of 1.5% or 5.0% ethanol (v/v) per day per mouse, up to 10 weeks) resulted in the elevation of colonic levels of oxidative stress markers (such as 8-hydroxy-2'-deoxyguanosine and 4-hydroxynonenal) compared to control mice, and this was consistently accompanied by elevated levels of inflammation-associated cytokines and immune cells (Th17 and macrophages) and a decreased level of regulatory T (Treg) cells to produce colonic lesions. It also resulted in an alteration of mouse fecal microbiota structures, reminiscent of the alterations observed in human inflammatory bowel disease, and this appeared to be consistent with the proposed sustained generation of oxidative stress in the colonic environment during chronic ethanol consumption. Moreover, the first experimental evidence that chronic ethanol administration results in elevated levels of advanced glycation end products (AGEs) and their receptors (RAGE) in the colonic tissues in mice is also shown, implying enhanced RAGE-mediated signaling with chronic ethanol administration. The RAGE-mediated signaling pathway has thus far been implicated as a link between the accumulation of AGEs and the development of many types of chronic colitis and cancers. Thus, enhancement of this pathway likely exacerbates the ethanol-induced inflammatory states of colonic tissues and might at least partly contribute to the pathogenesis of ER-CRC.

Indexed as

MicrobiotaOxidative StressAdministration, OralAnimalsBacteriaBiomarkersBody WeightChemokinesColonColorectal NeoplasmsEthanolFecesGastrointestinal MicrobiomeInflammationMaleMiceBiomarkersChemokinesEthanolRNA, Messenger

Identifiers

PMID33577585
PMCPMC7880462
OpenAlexW3127585871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.